In this study, we analyzed the expression of intratumoral CCR8 and the impact of CCR8 expression on recurrence-free survival (RFS) in a large cohort of ccRCC patients without synchronous metastatic diseases. The gene discussed is CCR8; the disease is nonpapillary renal cell carcinoma.